Intracranial Aneurysm Market registered a valuation of USD 1.37 billion in 2024 and is expected to reach USD 4.19 billion by 2037, rising at a CAGR of 9% during the forecast period, i.e., 2025-2037. In 2025, the industry size of intracranial aneurysm is estimated at USD 1.49 billion.
The primary growth driver is the rising prevalence of neurological disorders and intracranial aneurysms globally. According to the Institute for Health Metrics and Evaluation (IHME), neurological disorders were the top contributor to the global disease burden in 2021, affecting 43% of the world’s population.
The growing prevalence of conditions such as hypertension, smoking, excessive alcohol consumption, and obesity significantly contributes to the risk of intracranial aneurysms. Aging populations globally also face higher risks of developing aneurysms, boosting demand for diagnostic and treatment solutions. The development of advanced imaging techniques, such as CT angiography, MRI, and digital subtraction angiography (DSA), has improved early detection and diagnosis of intracranial aneurysms. Enhanced accuracy in diagnosing asymptomatic aneurysms drives treatment adoption rates.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
9% |
|
Base Year Market Size (2024) |
USD 1.37 billion |
|
Forecast Year Market Size (2037) |
USD 4.19 billion |
|
Regional Scope |
|
Type (Surgical Clipping, Endovascular Coiling, and Flow Diverters)
By type, the endovascular coiling segment is projected to capture intracranial aneurysm market share of around 86.2% by the end of 2037. The market growth is attributed to technological advancements, increased patient awareness, and the push for minimally invasive healthcare solutions. The minimally invasive treatment option is becoming increasingly popular due to its safety, efficacy, and shorter recovery times compared to traditional surgical methods like clipping. According to a 2023 published report by the American Society of Plastic Surgeons (ASPS), the number of minimally invasive procedures increased by 7% annually.
Rising detection rates of intracranial aneurysms, driven by advancements in diagnostic technologies, are boosting the demand for treatment options like endovascular coiling. Favorable insurance and reimbursement policies for minimally invasive procedures are encouraging more patients to opt for coiling. Moreover, increased training of neurosurgeons and interventional radiologists in endovascular techniques is supporting the growth of the segment.
End use (Hospitals and Clinics)
By end use, the hospital segment in intracranial aneurysm market is poised to register a profitable revenue share during the forecast period. Hospitals are equipped with advanced diagnostic tools, such as CT scans, MRI, and angiography systems, which are crucial for detecting and evaluating intracranial aneurysms. Many hospitals have dedicated neurovascular or neurosurgical units, staffed with skilled professionals trained to manage complex cases, including aneurysm surgeries and endovascular procedures. Further, hospitals adopt the latest technologies, such as robotic-assisted surgeries and AI-driven imaging tools, to enhance the accuracy and safety of aneurysm treatments.
Moreover, many hospitals collaborate with research institutions and medical device companies to pioneer new treatment methods, further driving their role in the market. public hospitals often receive government funding for neurology departments, making treatments more accessible to a broader population.
Our in-depth analysis of the global intracranial aneurysm market includes the following segments:
|
Type |
|
|
End use |
|
North America Market Forecast
North America in intracranial aneurysm market is likely to account for more than 29.7% revenue share by the end of 2037. The market growth can be attributed to a combination of technological advancements, increasing prevalence of risk factors, and robust healthcare infrastructure. High rates of hypertension, smoking, obesity, and alcohol consumption contribute to the increasing prevalence of intracranial aneurysms in the region.
The U.S. has a rising rate of hypertension, smoking, obesity, and alcohol consumption, which increases the risk of developing aneurysms. According to the United States Department of Health and Human Services, from August 2021 to August 2023, the prevalence of hypertension among people aged 18 and older was 47.7%. Adults aged 18-39 had a prevalence of 23.4%, which increased to 52.5% for ages 40-59 and 71.6% for those aged 60 and older. The country is home to numerous specialized neurology and neurosurgery centers offering state-of-the-art diagnostic and treatment options for intracranial aneurysms. A well-established emergency care infrastructure ensures prompt treatment of ruptured aneurysms, reducing mortality rates and improving outcomes.
Moreover, comprehensive health insurance policies in the U.S. cover a wide range of diagnostic and treatment options for intracranial aneurysms, reducing financial barriers for patients. Also, the presence of major industry players like Medtronic, Stryker, and Penumbra is driving innovation and ensuring the availability of advanced products.
In Canada, the rising adoption of minimally invasive procedures such as endovascular coiling and flow diverters is a significant growth factor. These treatments are preferred due to shorter recovery times and reduced surgical risks. The country also has a growing patient population with intracranial aneurysms, which drives the demand for diagnosis and treatment options. This is accompanied by heightened awareness of neurological conditions and their management.
APAC Market Analysis
The intracranial aneurysm market of Asia Pacific is poised to register the fastest revenue growth by 2037. The region has seen significant advancements in diagnostic and treatment technologies. Additionally, minimally invasive procedures are gaining traction for their effectiveness and safety. APAC has immense potential for continued development and innovation in treatment methods and healthcare infrastructure improvement.
India is emerging as a hub for medical tourism due to the cost-effectiveness of surgeries. This is driving domestic as well as international patients, thus boosting the intracranial aneurysm market. also, the country’s healthcare spending has been rising steadily, with the government allocating 2.1% of its GDP to health in 2023, reflecting a focus on advanced treatments such as minimally invasive procedures for aneurysms.
In China, the government’s commitment to enhancing healthcare systems, coupled with rising private investments, supports the adoption of innovative aneurysm treatment technologies. The overall healthcare expenditure is projected to grow further fostering intracranial aneurysm market expansion.
Key players are investing in R&D to improve the effectiveness of treatments like endovascular coiling and flow diversion. The emphasis on partnerships and expansion into emerging intracranial aneurysm markets is also boosting their market influence.
Some prominent key players include:
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?